RT Book, Section A1 Neumann, Ignacio A1 Akl, Elie A. A1 Vandvik, Per Olav A1 Alonso-Coello, Pablo A1 Santesso, Nancy A1 Murad, M. Hassan A1 Spencer, Frederick A1 Schünemann, Holger J. A1 Guyatt, Gordon A2 Guyatt, Gordon A2 Rennie, Drummond A2 Meade, Maureen O. A2 Cook, Deborah J. SR Print(0) ID 1183878256 T1 Assessing the Strength of Recommendations: The GRADE Approach T2 Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 978-0-07-179071-0 LK jamaevidence.mhmedical.com/content.aspx?aid=1183878256 RD 2024/04/19 AB CLINICAL SCENARIOYou are a primary care practitioner considering the possibility of the use of aspirin for primary prevention of serious cardiovascular events and cancer in a 60-year-old man. He has hypertension, adequately controlled with thiazides, but he is otherwise healthy; he does not have diabetes or dyslipidemia, does not smoke, and has no family history of heart disease.To inform your decision, you search first for an evidence-based recommendation and find the following: “In many adults, the benefits of aspirin exceed the risks (principally bleeding). For individuals 50 years or older without excess bleeding risk, we suggest low-dose daily aspirin (75-100 mg) (weak recommendation based on moderate confidence in effect estimates).”1After reading the corresponding Users' Guide (see Chapter 26, How to Use a Patient Management Recommendation: Clinical Practice Guidelines and Decision Analyses), you know that weak recommendations reflect the judgment of a specific group (eg, a guideline panel) that an individualized decision is necessary. You are curious, however, about the rationale for a weak recommendation for aspirin use and decide that this is a good opportunity to understand more about the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to move from evidence to recommendations.